Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjali T Owens

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Circulation. Genomic and Precision Medicine|June 7, 2018
Decoding Dysfunction in Duchenne Muscular Dystrophy CardiomyopathyNosheen Reza, Anjali T Owens
JAMA|March 18, 2017
Recreational Exercise in Hypertrophic CardiomyopathyAnjali T Owens, Thomas P Cappola
Journal of the American College of Cardiology|February 19, 2025
Expert Curation of Genes Associated With Hypertrophic Cardiomyopathy: What to Leave In, What to Leave OutMark V Sherrid, Anjali T Owens, Daniele Massera
The New England Journal of Medicine|March 26, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy. ReplyMilind Y Desai, Anjali T Owens, Iacopo Olivotto
Cardiac Failure Review|April 18, 2022
Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection FractionAnjali Agarwalla, Jadry Gruen, Carli Peters, et al.
Journal of Cardiac Failure|May 1, 2022
A Parallel Need for Cardiovascular Care for Female Carriers of Duchenne and Becker Muscular DystrophyTeresa Wang, Sharlene M Day, Lee R Goldberg, et al.
The International Journal of Cardiovascular Imaging|February 22, 2015
Clinical echocardiographic indices of left ventricular diastolic function correlate poorly with pulmonary capillary wedge pressure at 1 year following heart transplantationDavid R Okada, Maria R Molina, Maria Kohari, et al.
Circulation|December 20, 2018
Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited CardiomyocytesWenjian Lv, Lyon Qiao, Nataliya Petrenko, et al.
Journal of the American Heart Association|August 29, 2024
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual ResponseAnjali T Owens, Milind Desai, Matthew T Wheeler, et al.
Journal of Medical Economics|May 12, 2023
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United StatesSrihari S Naidu, Megan B Sutton, Wei Gao, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Circulation. Genomic and Precision Medicine|June 7, 2018
Decoding Dysfunction in Duchenne Muscular Dystrophy CardiomyopathyNosheen Reza, Anjali T Owens
JAMA|March 18, 2017
Recreational Exercise in Hypertrophic CardiomyopathyAnjali T Owens, Thomas P Cappola
Journal of the American College of Cardiology|February 19, 2025
Expert Curation of Genes Associated With Hypertrophic Cardiomyopathy: What to Leave In, What to Leave OutMark V Sherrid, Anjali T Owens, Daniele Massera
The New England Journal of Medicine|March 26, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy. ReplyMilind Y Desai, Anjali T Owens, Iacopo Olivotto
Cardiac Failure Review|April 18, 2022
Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection FractionAnjali Agarwalla, Jadry Gruen, Carli Peters, et al.
Journal of Cardiac Failure|May 1, 2022
A Parallel Need for Cardiovascular Care for Female Carriers of Duchenne and Becker Muscular DystrophyTeresa Wang, Sharlene M Day, Lee R Goldberg, et al.
The International Journal of Cardiovascular Imaging|February 22, 2015
Clinical echocardiographic indices of left ventricular diastolic function correlate poorly with pulmonary capillary wedge pressure at 1 year following heart transplantationDavid R Okada, Maria R Molina, Maria Kohari, et al.
Circulation|December 20, 2018
Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited CardiomyocytesWenjian Lv, Lyon Qiao, Nataliya Petrenko, et al.
Journal of the American Heart Association|August 29, 2024
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual ResponseAnjali T Owens, Milind Desai, Matthew T Wheeler, et al.
Journal of Medical Economics|May 12, 2023
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United StatesSrihari S Naidu, Megan B Sutton, Wei Gao, et al.
Pageof 9